搜索
Scinai Immunotherapeutics Ltd
SCNI添加自选
0.238USD
+0.007+3.26%
交易中 （美东）报价延迟15分钟
824.05K总市值
亏损市盈率 TTM
关于 Scinai Immunotherapeutics Ltd 公司
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Scinai Immunotherapeutics Ltd简介
公司代码SCNI
公司名称Scinai Immunotherapeutics Ltd
上市日期Jun 07, 2007
CEOReichman (Amir)
员工数量31
证券类型Depository Receipt
年结日Jun 07
公司地址Jerusalem Biopark, 2Nd Floor
城市JERUSALEM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Israel
邮编00000
电话97289302529
网址https://www.scinai.com/
公司代码SCNI
上市日期Jun 07, 2007
CEOReichman (Amir)
Scinai Immunotherapeutics Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Mark S. Germain
Mr. Mark S. Germain
Chairman of the Board
Chairman of the Board
120.00M
--
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
19.51K
+58.60%
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
4.87K
+73.89%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
1.18K
+76.63%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-36.00%
Dr. Yael Margolin
Dr. Yael Margolin
External Director
External Director
50.00
--
Mr. Adi Raviv
Mr. Adi Raviv
External Director
External Director
50.00
--
Mr. Samuel J. Moed
Mr. Samuel J. Moed
Director
Director
--
--
Dr. Morris C. Laster, M.D.
Dr. Morris C. Laster, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Mark S. Germain
Mr. Mark S. Germain
Chairman of the Board
Chairman of the Board
120.00M
--
Mr. Amir Reichman
Mr. Amir Reichman
Chief Executive Officer, Director
Chief Executive Officer, Director
19.51K
+58.60%
Mr. Elad Mark
Mr. Elad Mark
Chief Operating Officer
Chief Operating Officer
4.87K
+73.89%
Dr. Tamar Ben-Yedidia
Dr. Tamar Ben-Yedidia
Chief Scientific Officer
Chief Scientific Officer
1.35K
--
Mr. Uri Ben-Or, CPA
Mr. Uri Ben-Or, CPA
Chief Financial Officer
Chief Financial Officer
1.18K
+76.63%
Prof. Avner Rotman
Prof. Avner Rotman
Director
Director
50.00
-36.00%
常见问题
Scinai Immunotherapeutics Ltd的前五大股东是谁？
Scinai Immunotherapeutics Ltd 的前五大股东如下：Mr. Mark S. Germain
有多少机构持有Scinai Immunotherapeutics Ltd(SCNI)的股份？
截至2026Q1，共有23家机构持有Scinai Immunotherapeutics Ltd的股份，合计持有的股份价值约为179.71K，占公司总股份的5.08%。与2025Q4相比，机构持股有所增加，增幅为33890.00。